Alseres Pharmaceuticals, Inc. (NASDAQ: ALSE) to Hold Conference Call Reviewing 2008 Results on April 1

Alseres Pharmaceuticals, Inc. (NASDAQ: ALSE) will be holding a conference call on Wednesday, April 1, 2009 at 9:00 a.m. ET to review 2008 results.

The conference call can be accessed by dialing 1.877.856.1968 for domestic calls and 1.719.325.4770 for international calls. When prompted enter access code 2264513. Please dial in 5 to 10 minutes prior to scheduled start time to ensure access. The Alseres Pharmaceuticals conference call will be available for replay through the Investor Relations page on the company’s website within 48 hours following the call. The replay will be available through April 15, 2009.

Alseres Pharmaceuticals, Inc. (ALSE) is engaged in the development of therapeutic and diagnostic products primarily for disorders in the central nervous system (CNS). The Company maintains a world-class intellectual property position in the field of regenerative therapeutics. The Company's energy and focus is reflected in several important initiatives

Click here for more Business News 

About The Global Market Directory (TheGMD) 

TheGMD provides an online global directory listing featuring public companies, stock brokers, brokerage firms and individuals.  The GMD provides profiles for Brokerage Firms, Stock Brokers and Individuals in addition to Public Companies. 

The GMD is a division of TransWorldNews, Inc. Companies can utilize the TransWorldNews press release distribution services and have all news releases attached to their GMD profile.